Navigation Links
Treatment Programs Benefit Depressed Workers
Date:9/25/2007

ial productivity."

Personal suffering aside, depression costs the United States tens of billions of dollars a year, largely as a result of lost productivity. The malady is, according to background information in the study, one of the most costly health problems for employers.

And, while there are effective treatments, not everyone dealing with depression is treated or is treated well.

For this study, the first to be conducted exclusively among employed people, 604 employees with depression who were covered by a managed care behavioral health plan were randomly assigned to either to a care management program or to usual care. Employees with lifetime bipolar disorder, substance-abuse issues, suicidal tendencies, or recent mental health specialty care were excluded from the study.

The intervention effort consisted of telephone outreach and care management with a clinician who helped guide the employees through treatment.

"The care manager conducted outreach with workers who were identified as being depressed, tried to educate them about what depression was and tried to encourage them to get treatment if the symptoms were serious and not resolving," Wang explained. "When they got into treatment, the care manager tried to support them."

For example, if the patient was experiencing side effects from medication, the manager would encourage them to talk to their doctor and help them stay on the medication. If the patient was not interested in traditional, in-person treatments, the care manager would deliver psychotherapy via telephone. There were no restrictions on the type of treatment a patient could seek.

"By design, we wanted the intervention to be both feasible and very inexpensive," Wang said.

The "usual care" program consisted of screening as well as "nudging" the person toward treatment.

After six months and also one year, measurements of depression severity were signifi
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Thyroid hormone treatment hastens recovery after cardiac surgery
4. Feeding channel created by malaria parasite - a new target for malaria treatments
5. Now umbilical cord helps in stroke treatment.
6. Now AIDS treatment comes dirt-cheap
7. Breast cancer treatment to be determined by gene test
8. Hemopurifier may revolutionise AIDS treatment
9. New drug helps boost cancer treatment
10. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
11. Experimental treatment for Ebola Virus Shows promising results in mice

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009).... 20 Following a recall by Unileve...from sale Shedd,s Country Crock ® Side Dishes...Crock ® Side Dishes DELUXE Four Cheese Pasta ...following code dates and UPCs are affected: ,, ...heddar Broccoli Rice 21 oz, UPC 027400218316, Best...
(Date:11/20/2009)...PRNewswire-USNewswire/ -- The American Dental Asso...dministration (FDA) to establish appropriate class...iting concern about the safety of whitening produc... of professional consultation or examination by a ... of chemically based tooth whitening or bleaching ...
(Date:11/20/2009)...., Nov. 20 Samuel Gladd...ine what it means to be "happy" during the holiday...cialty in family counseling and chair of the Depar...dding says research shows that it is the pressure ...epression during the holidays. ,, That,s why he...
(Date:11/20/2009)...ne November 20 in the Journal of the National Can... hopes that often appear in news coverage of cance...th the media and journals to help alleviate the pr...n Woloshin, M.D., M.S., of Center for Medicine and...olicy and Clinical Practice in New Hampshire, and ...
(Date:11/20/2009)...ber 20, 2009Emergency medical service (EMS) provid...00 cardiac arrests each year. Only 5 to 10 percen.... Better quality cardiopulmonary resuscitation (C...ssociated with better patient outcome. The Resusc...linical research network to study prehospital trea...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...ch 5 Peregrine Pharmaceuticals, Inc. (Nasdaq: P...ancial results for the third quarter of fiscal yea... host a conference call and webcast to discuss the... 2009 and will review recent operating highlights....
...eives EU and US Approvals for Intravenous Formulat...l Temozolomide Sachet Presentation , , KENILWORTH...: SGP ) today announced that the European Commis...emozolomide is marketed as TEMODAL(R) in the EU an...
... Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) tod...l year 2008 financial results after the NASDAQ Glo...at same afternoon, Jack Lief, Arena,s President an.... Eastern Time (2:00 p.m. Pacific Time) to discuss...
...., March 5 Smith & Nephew Inc,s Advanced Woun...y announced the U.S. launch of its next Negative P...SYS (TM) GO, designed to address the needs of cli...wound care. The U.S. Food and Drug Administration ...
...acquisition of NMHC drives GAAP earnings per share...4 2008, up from $6.5 million in Q4, 2007, ,...C Health Solutions Corp. ("SXC" or the "Company") ... in U.S. dollars unless otherwise indicated. , "20...
...e demand for a reliable, non-invasive, efficient a...s, lifestyles is boosting interest in bone growth ...t is however still small, as clinicians have felt ... research papers to substantiate the efficacy of t...
Other Medicine News:Health News:Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results 2Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 2Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 3Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 4Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 5Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 6Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 7Health News:Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009 2Health News:Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009 3Health News:Smith & Nephew Introduces RENASYS(TM) GO, Portable NPWT for Mobile, Active Patients 2Health News:Smith & Nephew Introduces RENASYS(TM) GO, Portable NPWT for Mobile, Active Patients 3Health News:Smith & Nephew Introduces RENASYS(TM) GO, Portable NPWT for Mobile, Active Patients 4Health News:Smith & Nephew Introduces RENASYS(TM) GO, Portable NPWT for Mobile, Active Patients 5Health News:SXC Health solutions announces strong fourth quarter and year end financial results 2Health News:SXC Health solutions announces strong fourth quarter and year end financial results 3Health News:SXC Health solutions announces strong fourth quarter and year end financial results 4Health News:SXC Health solutions announces strong fourth quarter and year end financial results 5Health News:SXC Health solutions announces strong fourth quarter and year end financial results 6Health News:SXC Health solutions announces strong fourth quarter and year end financial results 7Health News:SXC Health solutions announces strong fourth quarter and year end financial results 8Health News:SXC Health solutions announces strong fourth quarter and year end financial results 9Health News:SXC Health solutions announces strong fourth quarter and year end financial results 10Health News:SXC Health solutions announces strong fourth quarter and year end financial results 11Health News:SXC Health solutions announces strong fourth quarter and year end financial results 12Health News:SXC Health solutions announces strong fourth quarter and year end financial results 13Health News:SXC Health solutions announces strong fourth quarter and year end financial results 14Health News:SXC Health solutions announces strong fourth quarter and year end financial results 15Health News:SXC Health solutions announces strong fourth quarter and year end financial results 16Health News:SXC Health solutions announces strong fourth quarter and year end financial results 17Health News:SXC Health solutions announces strong fourth quarter and year end financial results 18Health News:SXC Health solutions announces strong fourth quarter and year end financial results 19Health News:SXC Health solutions announces strong fourth quarter and year end financial results 20Health News:According to Frost & Sullivan, Mounting Clinical Evidence Underlines Benefits of Bone Growth and Spinal Fusion Stimulators 2Health News:According to Frost & Sullivan, Mounting Clinical Evidence Underlines Benefits of Bone Growth and Spinal Fusion Stimulators 3
(Date:11/20/2009)... Boston Scientific Corpor...eceived 510(k) clearance from the U.S. Food and Dr...rket its WallFlex® Fully Covered Esophageal S...ictures (obstructions) caused by tumors in patient...cer. ,, (Photo: http://www.newscom.com/cgi-b...
(Date:11/20/2009)...tCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) today ...utive Officer, and Greg Browne, Chief Financial Of...ay Health Care Conference in New York on Wednesday...e session and webcast will be audio only and no fo... host a webcast of the presentation live and by re...
(Date:11/20/2009)...swire-FirstCall/ -- BD (Becton, Dickinson and Comp... of its acquisition of HandyLab, Inc., an Ann Arbo...ctures molecular diagnostic assays and automation ...unced an exclusive agreement for BD to develop and...guar(TM) platform, the first fully integrated mole...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 1Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 2Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 3Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo Regeneration 50500 1Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo Regeneration 50500 2Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo Regeneration 50500 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 1Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 2Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 4
...y 8 VION PHARMACEUTICALS,INC. (Nasdaq: VION ) to...ed,Phase I/II clinical trial of its lead anticance...with cytarabine in elderly patients with,previousl...igh-risk,myelodysplastic syndromes (MDS). The tria...K. Ritchie, M.D. at The Weill-Cornell Medical Coll...
...tering Cancer Center Investigators to Assess BSI-2...er Patients -, BRISBANE, Calif., May 8 BiPar Sci... 2 clinical trial programs for its lead,product, B... clinical trial,of BSI-201 that BiPar has launched...s in breast and brain cancer., The company is eva...
Other Medicine Technology:Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2
Blue Line® Uncuffed Nasal Endotracheal Tubes (Ivory) Magill
Blue Line® Cuffed Cut-to-Length Oral/Nasal Endotracheal Tubes (clear PVC) Murphy
Uncuffed Nasoral Murphy
Super Safety Magill Cuffed Pediatric ET
Medicine Products: